Alligator Bioscience
0.20 SEK
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Alligator Bioscience
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 133.48 | 100.49 | 36.97 | 22.30 | 16.35 | 5.91 | 0.34 |
| Shares | 5.6 | 5.6 | 15.3 | 15.3 | 27.7 | 31.9 | 43.8 |
| Market cap | 753.9 | 567.5 | 566.9 | 341.9 | 453.3 | 188.8 | 14.8 |
| Enterprise value | 574.0 | 476.3 | 298.5 | 269.1 | 403.3 | 168.1 | - |
| EV/S | 131.7 | 109.4 | 23.1 | 7.5 | 6.9 | 2.9 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 2.92 | 4.92 | 2.01 | 3.84 | 38.22 | -1.45 | 2.15 |
| P/S | 173.0 | 130.4 | 43.8 | 9.6 | 7.8 | 3.3 | 28.7 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 83.1 % | 75.8 % | 84.7 % | 52.5 % | 10.0 % | -125.2 % | 6.2 % |
| Gearing ratio | 6.6 % | 10.5 % | 3.4 % | 27.5 % | 135.7 % | -33.4 % | 628.5 % |